A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

PHASE2UnknownINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Atopic Dermatitis
Interventions
DRUG

TQH2722 injection 300mg-150mg

TQH2722 injection is a fully human monoclonal antibody that interfering with the signal cascade.

DRUG

TQH2722 injection 600mg-300mg

TQH2722 injection is a fully human monoclonal antibody that thereby interfering with the signal cascade.

DRUG

TQH2722 injection 900mg-450mg

TQH2722 injection is a fully human monoclonal antibody that thereby interfering with the signal cascade.

DRUG

TQH2722 injection matching Placebo

Placebo without active substance.

Trial Locations (32)

25700

RECRUITING

Shengli Oil Field Central Hospital, Dongying

110000

RECRUITING

The First Affiliated Hospital of China Medical University, Shenyang

124000

RECRUITING

Panjin Liaoyou Gem Flower Hospital, Panjin

130041

RECRUITING

The Second Hospital of Jilin University, Changchun

150000

RECRUITING

The second affiliated hospital of harbin medical university, Harbin

200040

RECRUITING

Huashan Hospital Affiliated to Fudan University, Shanghai

210042

RECRUITING

Qian-jin Lu, Nanjing

241000

RECRUITING

The First Affiliated Hospital of Wannan Medical College, Wuhu

250022

RECRUITING

Shandong First Medical University Affiliated Dermatology Hospital, Jinan

250063

RECRUITING

Qilu Hospital of Shandong University, Jinan

266000

RECRUITING

The Affiliated Hospital Of Qingdao University, Qingdao

300122

RECRUITING

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

310003

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

310009

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

317500

RECRUITING

The First People's Hospital of Wenling, Wenling

332000

RECRUITING

Affiliated Hospital of Jiujiang University, Jiujiang

410013

RECRUITING

The third xiangya hospital of central south university, Changsha

430000

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

442000

RECRUITING

Shiyan Renmin Hospital, Shiyan

450003

RECRUITING

People's Hospital of Henan province, Zhengzhou

455000

RECRUITING

Puyang District Hospital of Anyang City, Anyang

473000

RECRUITING

The First People's Hospital of Nanyang, Nanyang

510030

RECRUITING

Dermatology Hospital, Southern Medical University, Guangzhou

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

518020

RECRUITING

Shenzhen People's Hospital, Shenzhen

541001

RECRUITING

Affiliated Hospital of Guilin Medical University, Guilin

650000

RECRUITING

The First Affiliated Hospital of Kunming Medical University, Kunming

710032

RECRUITING

Air Force Medical University, Xi'an

710061

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

830000

RECRUITING

Xinjiang Uygur Autonomous Region People's Hospital, Ürümqi

056002

RECRUITING

Affiliated Hospital of Hebei Engineering University, Handan

050000

RECRUITING

The Forth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY